Study on the PRIority MEdicines in the European Union
SHAO Rong
SUN Hai-shun
YAN Jian-zhou
WANG Meng-yuan
Abstract：It is the consensus for the industry and government to enhance drug approval efficiency and promote drug innovation.This paper tries to analyze the background and incentive measures of PROority MEdicines in the Europe Union and discusses how to accelerate the evaluation process in our country based on the existing framework.
Keywords：priority medicinesEuropean Unioncomparative study
Publication Date：2017-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：6( 614-619 )